デスフルラン
出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2023/11/27 05:12 UTC 版)
参考資料
- Eger, Eisenkraft, Weiskopf. The Pharmacology of Inhaled Anesthetics. 2003.
- Rang, Dale, Ritter, Moore. Pharmacology 5th Edition. 2003.
- Martin Bellgardt: Evaluation der Sedierungstiefe und der Aufwachzeiten frisch operierter Patienten mit neurophysiologischem Monitoring im Rahmen der Studie: Desfluran versus Propofol zur Sedierung beatmeter Patienten. Bochum, Dissertation, 2005 (pdf)
- Susanne Lohmann: Verträglichkeit, Nebenwirkungen und Hämodynamik der inhalativen Sedierung mit Desfluran im Rahmen der Studie: Desfluran versus Propofol zur Sedierung beatmeter Patienten. Bochum, Dissertation, 2006 (pdf)
- Patel SS, Goa KL (1995). “Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia”. Drugs 50 (4): 742–67. doi:10.2165/00003495-199550040-00010. PMID 8536556.
- ^ John Varkey (2012年). “Cost Analysis of Desflurane and Sevoflurane: An Integrative Review and Implementation Project Introducing the Volatile Anesthetic Cost Calculator”. 2022年10月23日閲覧。
- ^ Fang (1995年). “Carbon Monoxide Production from Degradation of Desflurane”. Anesthesia and Analgesia. 2022年10月23日閲覧。
- ^ Hugh C. Hemmings; Philip M. Hopkins (2006). Foundations of Anesthesia: Basic Sciences for Clinical Practice. Elsevier Health Sciences. pp. 290–291. ISBN 0-323-03707-0
- ^ Ronald D. Miller; Lars I. Eriksson; Lee A Fleisher; Jeanine P. Wiener-Kronish; Neal H Cohen; William L. Young (20 October 2014). Miller's Anesthesia. Elsevier Health Sciences. pp. 624–. ISBN 978-0-323-28011-2
- ^ Koichi Nishikawa & Neil L. Harrison (2003). “The actions of sevoflurane and desflurane on the gamma-aminobutyric acid receptor type A: effects of TM2 mutations in the alpha and beta subunits”. Anesthesiology 99 (3): 678–684. doi:10.1097/00000542-200309000-00024. PMID 12960553.
- ^ Allan P. Reed; Francine S. Yudkowitz (2 December 2013). Clinical Cases in Anesthesia. Elsevier Health Sciences. pp. 101–. ISBN 978-0-323-18654-4
- ^ Paul Barash; Bruce F. Cullen; Robert K. Stoelting; Michael Cahalan; Christine M. Stock; Rafael Ortega (7 February 2013). Clinical Anesthesia, 7e: Print + Ebook with Multimedia. Lippincott Williams & Wilkins. pp. 470–. ISBN 978-1-4698-3027-8
- ^ Charles J. Coté; Jerrold Lerman; Brian J. Anderson (2013). A Practice of Anesthesia for Infants and Children: Expert Consult – Online and Print. Elsevier Health Sciences. pp. 499–. ISBN 978-1-4377-2792-0
- ^ Linda S. Aglio; Robert W. Lekowski; Richard D. Urman (8 January 2015). Essential Clinical Anesthesia Review: Keywords, Questions and Answers for the Boards. Cambridge University Press. pp. 128–. ISBN 978-1-107-68130-9
- ^ Rote Liste Service GmbH (Hrsg.): Rote Liste 2017 - Arzneimittelverzeichnis für Deutschland (einschließlich EU-Zulassungen und bestimmter Medizinprodukte). Rote Liste Service GmbH, Frankfurt/Main, 2017, Aufl. 57, ISBN 978-3-946057-10-9, S. 175.
- ^ Ryan, Susan M.; Nielsen, Claus J. (July 2010). “Global Warming Potential of Inhaled Anesthetics: Application to Clinical Use”. Anesthesia & Analgesia (San Francisco, CA: International Anesthesia Research Society) 111 (1): 92–98. doi:10.1213/ane.0b013e3181e058d7 2011年9月9日閲覧。.
- ^ “Life Cycle Greenhouse Gas Emissions of Anesthetic Drugs”. Anesthesia and Analgesia 114 (5): 1086–1090. (May 2012). doi:10.1213/ANE.0b013e31824f6940.
- ^ “Inhalation anaesthetics and climate change”. British Journal of Anaesthesia 105 (6): 760–766. (July 2010). doi:10.1093/bja/aeq259. PMID 20935004.
- ^ Sherman. “Estimate of Carbon Dioxide Equivalents of Inhaled Anesthetics in the United States”. American Society of Anesthesiologists. American Society of Anesthesiologists. 2015年6月3日閲覧。
「デスフルラン」の続きの解説一覧
- デスフルランのページへのリンク
